Three-Sixty Advisory Group makes appointment
This article was originally published in Scrip
Three-Sixty Advisory Group, a US business accelerator, founded in 2007, that helps emerging healthcare and medical technology companies accelerate their growth, efficiency and capital, has added Dr Carlos Brown to its scientific advisory board. Dr Brown is the trauma medical director for University Medical Center Brackenridge in Austin, Texas.
You may also be interested in...
Brinavess Rejected By Advisory Cmte., Leaving US FDA To Mull Lifting Clinical Hold On Correvio's AFib Drug
Revised North American trade deal touted as enabling Congress to address crisis of high drug prices; requirement for 10 years biologic exclusivity is removed and language to allow incentives for generics added.
The Gilead subsidiary presented updated data at ASH for its first CD19-targeting CAR-T Yescarta and pivotal results for KTE-X19, which it plans to submit for US FDA approval in mantle cell lymphoma this year.